Concepedia

Viacheslav Morozov

VM

Statistics

Publications

6

Citations

497

H-Index

6

Active since

2022

Affiliations

Medizinische Hochschule Hannover(Current)

Goethe University Frankfurt

University of Milan

Gilead Sciences (United States)

Sechenov University

Viacheslav Morozov is an author at Medizinische Hochschule Hannover specializing in liver disease, viral hepatitis treatment, and pharmacy.

Publications per year

2022–2025

6

Publications

6

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D

Heiner Wedemeyer, Soo Aleman, Maurizia Rossana Brunetto et al. · New England Journal of Medicine · 2023 · 215 citations · Full text

, , +13

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov et al. · The Lancet Infectious Diseases · 2022 · 158 citations

, , +13

Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

Tarik Asselah, Vladimir Chulanov, Pietro Lampertico et al. · New England Journal of Medicine · 2024 · 80 citations · Full text

, , +11

Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide

Heiner Wedemeyer, Soo Aleman, Vladimir Chulanov et al. · Journal of Hepatology · 2024 · 19 citations · Full text

, , +16

Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg‐<scp>IFNα</scp>‐2a as Treatment for Chronic Hepatitis Delta

Pietro Lampertico, Vladimir Chulanov, Viacheslav Morozov et al. · Liver International · 2025 · 15 citations · Full text

, , +14

1–5 of 6